These results imply that both NETs and PAD4 inhibitors have a certain therapeutic effect on sepsis and could improve the associated coagulopathies, which is consistent with previously reported results (Biron et al., 2016; Zhao et al., 2016; Jiménez-Alcázar et al., 2017). Here, PADI4 is linked to blood coagulation disease.